SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding the Fairness of the Sale of Vitae Pharmaceutica...

The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Vitae Pharmaceuticals, Inc. (“Vitae Pharmaceuticals”) (NASDAQ: VTAE) stock prior to September 14, 2016.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Vitae Pharmaceuticals to Allergan plc for $21.00 per share. The transaction has a total approximate value of $639 million. To learn more about the action and your rights, go to:

http://zlk.9nl.com/vitae-pharmaceuticals-vtae

or contact Joseph E. Levi, Esq. either via email at [e-mail] or by telephone at [phone], toll-free: [phone]. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160915005921/en/

Levi & Korsinsky, LLPJoseph E. Levi, Esq.Eduard Korsinsky, Esq.Tel: [phone]Toll Free: 877-363-5972Fax: [phone]www.zlk.com